Il Dong Pharmaceutical Co Ltd (KO:249420) — Market Cap & Net Worth
Market Cap & Net Worth: Il Dong Pharmaceutical Co Ltd (249420)
Il Dong Pharmaceutical Co Ltd (KO:249420) has a market capitalization of $293.17 Million (₩432.61 Billion) as of August 4, 2026. Listed on the KO stock exchange, this Korea-based company holds position #14813 globally and #458 in its home market, demonstrating a -1.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Il Dong Pharmaceutical Co Ltd's stock price ₩13730.00 by its total outstanding shares 31508117 (31.51 Million). See Il Dong Pharmaceutical Co Ltd capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
Il Dong Pharmaceutical Co Ltd Market Cap History: 2016 to 2026
Il Dong Pharmaceutical Co Ltd's market capitalization history from 2016 to 2026. Data shows change from $320.26 Million to $293.17 Million (-2.67% CAGR).
Il Dong Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Il Dong Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Il Dong Pharmaceutical Co Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $320.26 Million | $201.34 Billion | $12.58 Billion | 0.00x | 0.03x |
| 2017 | $441.40 Million | $460.65 Billion | $19.84 Billion | 0.00x | 0.02x |
| 2018 | $413.35 Million | $503.91 Billion | $12.72 Billion | 0.00x | 0.03x |
| 2019 | $340.62 Million | $517.47 Billion | -$13.44 Billion | 0.00x | N/A |
| 2020 | $403.56 Million | $561.85 Billion | -$13.02 Billion | 0.00x | N/A |
| 2021 | $717.45 Million | $560.13 Billion | -$99.71 Billion | 0.00x | N/A |
| 2022 | $609.62 Million | $637.71 Billion | -$141.58 Billion | 0.00x | N/A |
| 2023 | $387.76 Million | $600.76 Billion | -$78.93 Billion | 0.00x | N/A |
| 2024 | $251.32 Million | $614.94 Billion | -$4.58 Billion | 0.00x | N/A |
Competitor Companies of 249420 by Market Capitalization
Companies near Il Dong Pharmaceutical Co Ltd in the global market cap rankings as of August 4, 2026.
Key companies related to Il Dong Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Il Dong Pharmaceutical Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Il Dong Pharmaceutical Co Ltd's market cap moved from $320.26 Million to $ 293.17 Million, with a yearly change of -2.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩293.17 Million | -64.34% |
| 2025 | ₩822.08 Million | +227.10% |
| 2024 | ₩251.32 Million | -35.19% |
| 2023 | ₩387.76 Million | -36.39% |
| 2022 | ₩609.62 Million | -15.03% |
| 2021 | ₩717.45 Million | +77.78% |
| 2020 | ₩403.56 Million | +18.48% |
| 2019 | ₩340.62 Million | -17.59% |
| 2018 | ₩413.35 Million | -6.36% |
| 2017 | ₩441.40 Million | +37.82% |
| 2016 | ₩320.26 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Il Dong Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $293.17 Million USD |
| MoneyControl | $293.17 Million USD |
| MarketWatch | $293.17 Million USD |
| marketcap.company | $293.17 Million USD |
| Reuters | $293.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Il Dong Pharmaceutical Co Ltd
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central n… Read more